|
EPS Est (next year)
(Dec-09)
: | 2.92 | |
EPS Est (in 2 years)
(Dec-10)
: | 3.35 | | Avg Rec (current)*: | 3.2 | | PEG Ratio: | 1.64 |
|
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, marketing, and sale of medical devices worldwide. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management.
» Full Company Profile | |
|